ECP 2024 Final Programme

Sunday, 8 Sept Computational Symposium 76 e Sunday, 8 September 2024 CP-01 Computational Symposium 08:30–12:00 Spadolini 2 The promise of computational pathology Chairs: Darren Treanor, United Kingdom Inti Zlobec, Switzerland 001 08:30–09:00 Multimodal AI for pathology Faisal Mahmood, USA 002 09:00–09:30 Large-scale validation of AI-assisted mitosis counting in breast cancer Leslie Tessier, The Netherlands 003 10:30–11:00 AI for prediction of malignant transforma- tion of oral dysplasia Ali Khurram, United Kingdom 004 11:00–11:15 Pros and cons of digital pathology in nephropathology based on the experience of 220 cases Fadime Gül Salman, Turkey S. M. Ünlü 005 11:15–11:30 The re-stAIn algorithm: development and validation of an artificial-intelligence based tool for slides synthetic restaining Alessandro Gambella, Italy N. Michielli, L. Salamone, A. Mogetta, L. Molinaro, M. Papotti, F. Molinari, M. Salvi 006 11:30–11:45 From AI development to clinical implemen- tation: prospective deep learning-assisted lymph node screening for colorectal cancer patients Abdul Latif Khan, Saudi Arabia S. Reinhard, A. Perren, B. Dislich, I. Zlobec 007 11:45–12:00 ODYN: an artificial intelligence-based pipeline for the prediction of malignant transformation in oral epithelial dysplasia Adam Shephard, United Kingdom H. Mahmood, S. Raza, A. Khurram, N. Rajpoot CP-02 Computational Symposium 14:45–16:45 Spadolini 2 Recent developments and validation Chairs: Jeroen Van Der Laak, The Netherlands Antonio Polonia, Portugal 001 14:45–15:15 Vision-language models for pathology Matthew G. Hanna, USA 002 15:15–15:45 Validation of digital pathology Bethany Williams, United Kingdom 003 15:45–16:00 Molecular classification of endometrial cancer from H&E stained slide images using supervised deep learning: a proof of concept Fabiana Inés Aguirre Neira, Spain V. E. Rodriguez, Á. A. Legoburu, A. R. Llanos, R. Carrera Salas, O. Jiménez Bolancé, J. C. Ferreres Piñas, I. Costa Trachsel 004 16:00–16:15 Deep learning-aided molecular subtyping of pulmonary large cell neuroendocrine carcinoma in small hematoxylin and eosin-stained tissues Teodora-Elena Trandafir, The Netherlands F. Heijboer, F. Akram, J. Derks, Y. Li, E.-J. Speel, A. Stubbs, A.-M. Dingemans, J. von der Thüsen 005 16:15–16:30 Anti-tumour activity of eosinophils and intraepithelial lymphocytes in colorectal cancer: a two-pronged approach Elias Baumann, Switzerland P. Krebs, A. Perren, R. Kirsch, M. D. Berger, I. D. Nagtegaal, I. Zlobec 006 16:30–16:45 Deep learning predicts the effect of neo-adjuvant chemotherapy for patients with triple negative breast cancer Bart Sturm, The Netherlands P. Lock, D. Kumar, J. Westerga, W. Blokx, J. van der Laak